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Background: Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disorder that involves the
infundibular terminal follicles in areas rich of apocrine glands. It can be associated with fistulating sinus, scarring
and abscesses formation. Hidradenitis suppurativa is a challenging aspect and requires a proper treatment plan
which may involve different specialties. We present herein the option of surgical treatment involving wide surgical
excision and methods of reconstruction as well as the rate of recurrence. Furthermore, review of the literature
regarding surgical treatment of hidradenitis suppurativa is provided.
Methods: A retrospective analysis reviewed 50 operative procedures for 32 patients in 5 anatomical sites. These
anatomical sites have been divided to 23 sites involving the axilla, 17 sites involving the inguinal region and 8 sites
involving the perianal/perineal area, 1 site involving the gluteal region and 1 site involving the trunk region.
Results: Twenty six patients (81, 25 %) showed no recurrence after surgery and the average time of hospital stay
period was 5 days. Recurrence was observed only in 6 patients (18, 75 %).
Conclusion: Elimination of the acute inflammatory process should occur in advance, including the use of
antibiotics and minor surgeries such as abscess drainage with proper irrigations. After stabilizing the acute phase,
wide surgical excision is recommended. Herein, planning of surgical reconstruction should be initiated to achieve
the best outcome and consequently decreasing the risk of recurrence and complications after surgery.
Keywords: Hidradenitis suppurativa, Acne inversa, Follicular diseases, Surgical reconstruction, Wide surgical excisionBackground
Hidradenitis suppurativa (HS) is a chronic inflammatory
cutaneous disorder that involves the infundibular terminal
follicles in areas rich of apocrine glands and associated with
formation of abscesses and fistulating sinus [1-5]. The
pathogenesis of the disease is not fully understood, although
it was reported that HS is androgen dependent that can be
associated with endocrine abnormalities [6]. Bacterial infec-
tion is considered as a secondary event in the pathogenesis.
Furthermore, smoking and obesity are both known as risk
factors and may increase the severity of the disease [1,6].
Clinical manifestations include painful nodules, abscesses,
sinus tracts, and ropelike hypertrophic scars in the apocrine
gland-bearing areas [7]. Consequently, the abscesses extend
deeper into the subcutaneous tissue and then intercom-
municating sinus tracts develop, resulting in irregular* Correspondence: zalharbi@ukaachen.de
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reproduction in any medium, provided the orhypertrophic scars [8]. Hidradenitis suppurativa was
initially classified by using Hurley's Staging System
(Table 1) [9].
Likewise, Sartorius et al. have suggested that the Hurley
system is not enough to assess the efficacy of the treat-
ment. Therefore, they described the Sartorius Staging Sys-
tem. Points are accumulated in each category to assess the
treatment of HS in an accurate way [11]. The Sartorius
Staging System [12] accumulates points according to:
 Anatomic regions involved
 Number and types of lesions involved (abscesses,
nodules, fistulas, scars, points for lesions of all
regions involved)
 The distance between lesions, in particular the
longest distance between two relevant lesions (i.e.
nodules and fistulas in each region or size if only
one lesion present)
 The presence of normal skin in between lesionsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Hurley’s Staging System [10]
StageCharacteristics
I Solitary or multiple isolated abscess formation without scarring or
sinus tracts.
II Recurrent abscesses, single or multiple widely separated lesions,
with sinus tract formation. (Require minor surgery such as incision
and drainage.)
III Diffuse or broad involvement across a regional area with multiple
interconnected sinus tracts and abscesses
Table 2 shows the recurrence rate with the type of
surgical reconstruction in each site
Location of
Defects
(total number:50)
Methods of
reconstruction
Percentage of
usage related
to each region
Recurrence
Axilla Rotation
fasciocutaneous
flap
30,4 % 39,6 %
(7 sites) (2 patients)
46 % Transposition
fasciocutaneous
flap (Limberg flap)
39,1 % 11,1 %
Parascapular
fasciocutaneous
flap
(9 sites) (1 patient)
21,7 % 0 %
TDAP flap (5 sites)
ALTP flap 4,3 % 0 %
(1 site)
4,3 % 0 %
(1 site)
Inguinal Primary closure 47 % 12,5 %
34 % Split-thickness
skin graft
(8 sites) (1 patient)
Rotation
fasciocutaneous
flap
17,75 % 33,3 %
Transposition
fasciocutaneous
flap
(3 sites) (1 patient)
17,75 % 33,3 %
Abdominoplasty (3 sites) (1 patient)
11,8 % 0 %
(2 sites)
5,8 % 0 %
(1 site)
Perianal/
Perineal 16 %
Transposition
fasciocutaneous
flap
75 % 0 %
Gracilis
musculocutaneous
flap
(6 sites)
25 % 0 %
(2 sites)
Gluteal Split-thickness skin
graft
100 % 0 %
2 % (1 site)
Trunk Split-thickness skin
graft
100 % 0 %
2 % (1 site)
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treatment plan that may involve different specialties.
Hidradenitis suppurativa is commonly misdiagnosed and
sometimes even referred to many subspecialties [13]. In
general, treatment includes the use of topical or systemic
antibiotics, topical antiseptics and intralesional corticos-
teroids. Furthermore, systemic retinoids, antiandrogen
therapy, immunotherapy (TNF alfa inhibitors) and oral
immunosuppressive agents have also shown a positive
effect on disease progression [10,12]. However, for most
cases of advanced hidradenitis suppurativa, radical sur-
gery can be the only curative treatment option [14]. It is
also reported that early wide surgical excision is import-
ant and effective in order to prevent complications and
the recurrence of hidradenitis suppurativa and to im-
prove the quality of life [15].
This article focuses on the surgical treatment of hidra-
denitis suppurativa with special regard to the methods
of reconstruction for resulted defects after wide surgical
excision in the axilla, inguinal region, gluteal region,
trunk, perineal and perianal area. The rate of recurrence
will be also reviewed. Furthermore, a review of the lit-
erature regarding surgical treatment of hidradenitis sup-
purativa is provided.
Methods
This retrospective analysis reviewed 32 patients with
chronic inflammatory moderate to severe hidradenitis
suppurativa (Hurley grade II and III) treated in our hos-
pital from 2003 to 2009 (Table 2). Follow up of all
patients has been conducted in our out patient depart-
ment (OPD) with a mean period of 24 months after sur-
gery. 50 operative procedures were retrospectively
reviewed in 5 anatomical sites, 23 sites involving the ax-
illa, 17 sites involving the inguinal region and 8 sites in-
volving the Perianal/perineal area, 1 site involving the
gluteal region and 1 site involving the trunk region. The
regional ethics committee advised that approval was not
necessary for this retrospective analysis. However, all
patients have provided written informed consent for the
publication of their clinical details and any accompany-
ing clinical images.
Twelve patients (37,5 %) were males and 20 patients
(62,5 %) were females. The age at the time of presentationranged from 17 years to 51 years (Table 3). Overall, 22
patients (68,75 %) were obese. From this category, 5
patients (15,6 %) had Body Mass Index (BMI) of more
than 25 and 14 patients (43,75 %) had BMI of more than
30. Two patients (6,2 %) represented BMI of more than 35
Table 3 Patients characteristics with Age, Body Mass Index, Smoking and Size of Defect
Pat. No. Sex Age BMI Smoking Site Defect Size (cm) Recurrence
1 F 46 33.6 No Axilla 11 × 5,2 × 2 -
2 M 35 31.2 Yes Axilla 14 × 6,2 × 4 -
3 M 32 30.1 Yes Inguinal/Perianal 10,5 × 8 × 3,1 -
4 F 30 24.6 No Axilla 7× 4 × 2,5 -
5 F 32 26.3 No Inguinal/Perineal 10 × 4.5 × 2,3 -
6 F 39 29.8 No Axilla 6.3 × 5.8 ×1,5 -
7 F 21 24.9 No Axilla 6 × 5 × 1,5 -
8 M 36 33.2 Yes Inguinal 8 × 3 × 1 +−
9 F 24 33.7 No Axilla/Trunk 11 × 4 × 1,5 -
10 F 31 20.4 No Inguinal 9 × 3 × 1,5 +−
11 F 38 30.1 Yes Bilateral Axilla 6,8 × 6 × 2,5 +−
7 × 5,8 × 2,3
12 M 29 24.0 Yes Bilateral Axilla 3,5 × 4 × 1 +−
4 × 4 × 0,5
3 M 15 32.4 No Bilateral Axilla 7 × 6 x 28 × 5 ×1,5 -
14 M 21 24.8 No Axilla 12 × 4 × 0,8 -
15 F 37 38.8 No Bilateral Axilla 8 × 6 × 2,3 -
7 × 5 × 2,5
16 F 26 41.2 No Axilla 10 × 8 × 2,5 -
17 M 41 32.4 Yes Inguinal 5,5 × 3× 2 -
18 M 34 21.9 Yes Inguinal 8 × 4 × 3,5 +
19 F 25 31.2 No Inguinal 5 × 2 × 1 -
20 F 51 28.7 Yes Perineal/Perianal 8 × 4 × 2 -
21 M 26 27.8 Yes Axilla 9 × 7 ×3 +−
22 F 43 31.6 No Axilla 8,6 × 5 × 1,5 -
23 F 36 34.0 No Bilateral Perianal/Perineal 20 × 13 × 5 –
8 × 6 × 3
24 F 22 20.4 Yes Bilateral Inguinal 11,5×2,5×1,5 -
2,2×,8×,5
25 F 40 24.0 Yes Inguinal 6,5 × 4 × 0,8 -
26 F 30 18.4 No Inguinal 7 × 4,5 × 0,5 -
27 M 20 26.0 No Axilla 9 × 7 × 3 -
28 F 28 22.9 No Inguinal 3,7 × 1 × 2,1 -
29 M 50 31.1 Yes Bilateral Axilla 5,6×5,1,1,2 –
2,6 × 0,5 ×0,5
30 F 22 30.1 No Bilateral Inguinal 14 × 3 × 1,5 -
15 × 2 × 1,5 -
31 F 25 30.6 No Inguinal und Mons pubis 17 × 5 × 2,5 -
13 × 4 × 1,5
32 M 21 22.4 Yes Axilla 13 × 5 × 1,5 -
Alharbi et al. BMC Dermatology 2012, 12:9 Page 3 of 8
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than 40. The analysis also showed that 10 patients
(31,25 %) were smokers (5 males and 5 females).The patients had chronic inflammatory hidradenitis
suppurativa (Hurley grade II and III). Intravenous anti-
biotics were prescribed depending on wound tissue swab
Figure 1 Hidradenitis suppurativa (Hurley's Staging II) in the
left axilla.
Alharbi et al. BMC Dermatology 2012, 12:9 Page 4 of 8
http://www.biomedcentral.com/1471-5945/12/9and laboratory results. Minor surgeries such as abscess
drainage and irrigation were performed in order to irri-
gate the wounds. Further irrigation has been performed
in the surgical ward prior to the surgical procedure.
Wide surgical excisions were carried out for all patients
with wide margin (i.e. 1 cm) and deep margin including
the skin, subcutaneous tissue till reaching fascia. Stool
Management System (SMS) has been used to prevent
contamination of the stool to the surrounded skin other-
wise colostomy was conducted for selected patients with
perianal or perineal lesions. Then, reconstruction techni-
ques were conducted based on the site and the size of
the defects including primary closure, skin grafting,
local flaps as random pattern or pedicle pattern, re-
gional flaps and the more invasive free (microvascular)
tissue transfer in selected patients. The size of defects
resulted after excision ranged from 16,5 cm2 (5,5 x
3 cm) to 735 cm2 (35 x 21 cm). At the time of surgery,
all patients have been administrated with single dose
intravenous antibiotics depending on the previous swab
results. One-stage operations: wide surgical excision
and reconstruction of defect was performed for 26
patients (81,25 %). Two-stages operations have been
performed for 5 patients (15,63 %) buy using the nega-
tive pressure therapy in one stage and the reconstructive
art in the other stage. Only one patient has been oper-
ated in three stages (3,12 %) which included the use of
negative pressure therapy in one stage and other de-
bridement with irrigation due to persistent pus secre-
tions and then the reconstruction of defect in the third
stage.
For the axilla, rotation fasciocutaneous flap was per-
formed in 7 sites (30,4 %), and transposition fasciocuta-
neous flap including the Limberg flap was used in 9 sites
(39,1 %). Parascapular fasciocutaneous flap was selected
in 5 patients (21,7 %) and the thoracodorsal artery per-
forator (TDAP) flap was the option in 1 patient (4,3 %).
Anterolateral thigh perforator (ALTP) flap has been used
in 1 patient (4,3 %).
For inguinal lesions, primary closure was used in 8 sites
(47 %) and 3 Split-thickness skin grafting techniques
(17,75 %) were performed. Rotation fasciocutaneous flap
was used in 3 sites (17,75 %) and transposition fasciocuta-
neous flap was carried out in 2 sites (11,8 %). Only one pa-
tient (5,8 %) was treated with abdominoplasty for
reconstructing the defect involving the both inguinal areas
and Mons pubis.
Reconstruction of the perianal and the perineal regions
included the using of transposition fasciocutaneous flap
in 6 sites (75 %) and Gracilis musculocutaneous flap
was used in 2 patients (25 %). Reconstruction of the
trunk and gluteal region was carried out for only two
patients by performing a split thickness skin graft for
each site.Results
Daily dressing has been performed in a sterile concept.
Twenty eight Patients (87,5 %) showed no complications
after surgery. The average time of hospital stay period
was 5 days. Physiotherapy and post-operative rehabilita-
tion were also started.
After follow up (mean follow up time is 24 months),
26 Patients (81,25 %) showed no recurrence. Recurrence
rate (Tables 2 and 3) was observed in 6 patients
(18,75 %). The recurrence rate was seen in patients with
Hurley grade III and 5 smokers out of 6 patients in this
category (83,33 %).
Reconstruction of the axillary region included several
techniques but primary closure and skin grafting were
not performed based on expected complications such as
contractures, excessive scarring. For those lesions in this
area, rotation fasciocutaneous flap and transposition fas-
ciocutaneous flap such as Limberg flap were performed
successfully and showed good aesthetic as well as func-
tion results. Parascapular fasciocutaneous flap and even
thoracodorsal artery perforator (TDAP) flap were
selected for moderate to diffuse lesions. Massive lesions
in the axillary region were reconstructed in 1 of our
patients by the use of free (microvascular) tissue transfer
in the form of anterolateral thigh perforator (ALTP) flap
Figure 2 The resulted defect after wide surgical excision. Figure 4 Post-operative photo demonstrates no healing
abnormalities.
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(Figures 1, 2, 3, and 4).
Reconstruction of the inguinal region included pri-
mary closure for mild and moderate lesions. Likewise,
split-thickness skin grafting was selected for large
defects. Rotation fasciocutaneous flap and transposition
fasciocutaneous flap were performed successfully and
showed good aesthetic results. For bilateral inguinalFigure 3 Adaptation of the ALTP flap after vascular
anastomosis.lesions and involvement of Mons pubis, an abdomino-
plasty was performed for one patient and showed good
outcome.
For lesions located on the perianal and the perineal
regions, several techniques have been carried out includ-
ing the use of bilateral transposition flap (Figures 5, 6, 7,
8, and 9) or the using of Gracilis musculocutaneous flap
for severe lesions. Both techniques required preservationFigure 5 Bilateral Hidradenitis suppurativa (Hurley's Staging III)
in the perianal, perineal and mons pubis showing the left side.
Figure 6 Bilateral Hidradenitis suppurativa (Hurley's Staging III)
in the perianal, perineal and mons pubis showing the right
side.
Figure 8 Bilateral transposition flap used to cover large defects
bilaterally.
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in the gluteal and the trunk area, skin grafting was used
successfully.Discussion
The literature on surgical treatment of hidradenitis sup-
purativa is huge and the review of this disease goes back
to the 1950s [16-19]. Recently, many articles have been
published regarding this point and some recent key
references exist regarding surgical treatment of hidrade-
nitis suppurativa [20,21]. Primary closure, healing by
secondary intention and skin grafting are considered to be
the most widely used procedures. Furthermore, several
surgical techniques depending on secondary intention for
minor or extensive disease are also described in the litera-
ture [21].Figure 7 The resulted defect after wide surgical excision.In fact, 18,75 % recurrence rate can be considered high
after extensive surgery procedures. On the other hand,
this recurrence rate was strongly associated with the ex-
tent (Hurley grade) of disease. Herein, in very advanced
cases with Hurley grade III, it can be very hard to radic-
ally remove all HS tissue even if very extensive surgery
is applied and at least minor recurrence is expected and
accepted. Sartorius score cannot, but Hurley classifica-
tion with clinical margin evaluation can possibly give
valuable information for proper treatment options.
Excision and split skin grafting is a basic tool in the
surgical treatment and the result of this procedure is
often satisfactory [22-24]. Massive regional hidradenitis
suppurativa can be successfully managed with wide sur-
gical excision, VAC therapy, and skin grafting for better
outcomes [25]. Furthermore, Negative-pressure dres-
sings have been used as bolster for skin grafts in orderFigure 9 The post-operative result of the bilateral trasposition
flap.
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[26,27].
However, the use of flaps to prevent less favorable
functional results was introduced at an early stage. A re-
view of the Limberg flap for axillary hidradenitis was
presented quite recently [28]. Local fasciocutaneous V-Y
advancement flaps was reported for large defects follow-
ing wide surgical excision of long-standing hidradenitis
suppurativa of the axilla [29]. Other option is the double
opposing V-Y perforator-based flaps which have been
described for reconstruction of axillary defects following
excision of hidradenitis suppurativa to recreate the axil-
lary contour after wide surgical excision of the hair-
bearing skin of the axilla [30]. More options exist like
the use of a versatile transpositional flap for axillary
hidradenitis suppurativa [31]. Some flaps may be indi-
cated in particular cases such as the use of thoracodorsal
artery perforator flap (TDAP) in axillary hidradentitis
suppurativa [32,33]. Herein, lateral thoracic fasciocuta-
neous island flap was also used for treatment of recur-
rent hidradenitis axillaris suppurativa and other axillary
skin defects [34].
The pedicled gracilis myocutaneous flap has been intro-
duced as a surgical treatment of hidradenitis suppurativa of
the groin and perineum [35]. It was even proposed that the
medial thigh lift to be considered for immediate defect
closure after radical excision of localised inguinal hidradeni-
tis suppurativa provided that no perifocal signs of infection
are present after debridement [36]. Furthermore, modified
abdominoplasty was also reported as a functional recon-
struction for recurrent hidradenitis suppurativa of the
lower abdomen and groin [37]. The anterolateral thigh
(ALT) flap has been reported for reconstruction of groin
and vulval hidradenitis suppurativa [38]. Furthermore, the
anterior Obturator Artery Perforator (aOAP) flap seems to
be a save option for the reconstruction of perineal defects
after wide surgical excision of hidradenitis suppurativa [39],
although it was not introduced specifically for this disease.
It should be noted that the use of colostomy is not an
absolute indication for treating such defects in the peri-
anal or perineal region. We believe that flaps in these
areas are more susceptible to infections. Colostomy can
be performed but should be preserved for selected
patients with massive extensive defects. Some patients
do not agree with colostomy and, thus the consent of
this procedure does not apply in many cases. However,
this does not interfere with the selected treatment plan.
For buttocks, more options have been stated in the lit-
erature such as the fasciocutaneous flaps in gluteal
hidradenitis suppurativa [40]. Other options were also
documented such as the extended split superior gluteus
maximus musculocutaneous flap. This flap is easy to
harvest and leaves aesthetically satisfactory results [41].There is no doubt that this approach of treatment is
mainly dependent on the size and the site of the defect.
Despite the method of reconstruction, the hospitalization
period can be reduced and, thus reducing the cost of treat-
ment. This goal can be elusive and therefore radical exci-
sion and more advanced reconstruction techniques are
performed in order to close defects in a permanent way.
We found that wide surgical excision as well the direct
closure technique showed better outcome and limited the
cost of treatment and the hospitalization period as well as
the recurrence rate.
It is of great importance to determine the timing of
wide surgical excision and the selected method of recon-
struction. During the acute phase, surgical drainage, irri-
gation with the administration of antibiotics should only
be the mainstay of the treatment. Our approach has not
been conducted in this phase. It was important to obtain
a non-infectious wound to perform this approach and
not to expect septic complications. Then, planning of re-
construction should be initiated to achieve the best out-
come and consequently decreasing the risk of
recurrence and complications after surgery.
Conclusion
Treatment of hidradenitis suppurativa has wide modal-
ities. However, surgical option can be the option of treat-
ment especially for those severe cases being treated with
conservative modalities. After eliminating the acute in-
flammatory phase, wide surgical excision is recom-
mended and planning of reconstruction should be
initiated to achieve the best outcome and consequently
decreasing the risk of recurrence and complications after
surgery. Our concept of treatment including recon-
structive techniques decreased the time of hospital stay.
It is cost effective and prevented skin contractures as
well as excessive scarring and showed good functional
and aesthetic results.
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